Press Releases

 Filter by Provider

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Navan, Inc. (“Navan” or the “Company”) (NASDAQ: NAVN) and certain of its officers and/or directors, alleging violations of the federal securities laws. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

For customers looking for super ideal diamonds for sale, the online market can be a confusing space filled with technical jargon and unverifiable claims. Whiteflash, an internationally acclaimed jeweler, is offering expert guidance on how to navigate this search by focusing on transparent, verifiable data that empowers the buyer.

Flight of the Valkyrie delivers a gripping race against time aboard the International Space Station

Asheville, NC, March 17, 2026 (GLOBE NEWSWIRE) -- Caring for the Body, PLLC – Center for Functional Medicine, a physician-led medical practice based in Asheville, North Carolina, today announced the continued expansion of Re-Think Aging, a physician-led brain health and longevity platform founded by board-certified family physician Dr. Cynthia Libert, M.D. Through this initiative, Caring for the Body, PLLC is advancing a proactive, prevention-focused model designed to help adults protect cognitive health, reduce the risk of memory decline, and thrive throughout midlife and beyond.

Los Angeles, CA - March 17, 2026 - Unwanted clutter can be a big mess for everyone – whether for homeowners, property managers or businesses. However, the timely, effective and dedicated service offered by Junk Removal in LA can make this mess vanish fast. With a mission to simplify cleanup projects, it is helping residents and business owners to ensure impeccable hygiene all around, just the way it should be.

Palm Beach Gardens, FL - March 17, 2026 - Serenity Living Home Care, a boutique assisted living home in Palm Beach Gardens, strengthens its hurricane preparedness protocols ahead of forecasts for an above-average storm season, prioritizing senior resident safety with tailored measures.

JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.

Sydney, Australia - March 17, 2026 - Strengthening enterprise eCommerce capabilities in Australia through advanced Shopify Plus development expertise and scalable digital commerce solutions.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

Houston, Texas - March 17, 2026 - Author Adriene Caldwell announces the release of her debut memoir, Unbroken: Life Outside the Lines, available worldwide on March 17, 2026. The powerful and deeply personal memoir chronicles Caldwell's journey through childhood trauma, family instability, and adversity, while illuminating the resilience required to survive and ultimately reclaim one's voice.

WALTHAM, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced an upcoming poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place from April 17-22, 2026 at the San Diego Convention Center in San Diego, California.

First Farmers and Merchants Corporation (OTCID: FFMH), the holding company for First Farmers and Merchants Bank, today announced that its Board of Directors has declared the Company’s regular quarterly cash dividend of $0.29 per share, which will be paid on April 16, 2026, to shareholders of record as of April 1, 2026. The dividend represents a 7.4% increase compared with the cash dividend paid during the same period last year.

OMAHA, Neb., March 17, 2026 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced that it will host a conference call for investors on Thursday, March 19, 2026 at 4:30 p.m. Eastern Time to discuss the Partnership’s Fourth Quarter 2025 results. Additional information regarding the conference call is included below.

SEATTLE, March 17, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that updated data on the Company’s [212Pb]VMT-α-NET program have been accepted as a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 taking place from April 17 to 22, 2026 in San Diego, CA as detailed below. AACR has announced that it will release further details for clinical trial abstracts for the conference on April 17, 2026.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AMC Entertainment Holdings, Inc. (“AMC” or the “Company”) (NYSE: AMC; APE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

Speed and adaptability are crucial in contemporary product development. Nowadays, both start-ups and corporates face the necessity of quickly validating their ideas while managing limited resources and market uncertainty. Cloud-native architecture has emerged as a practical and reliable means of building scalable, flexible digital products that meet this demand. By leveraging cloud-based infrastructures, development teams can engineer, test, and deploy applications far more quickly than traditional approaches allow, and this shift has directly transformed how MVP Development Services are structured and delivered, enabling businesses to move from concept to validated product with significantly less time, cost, and technical risk than was previously possible

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced it will present new long-term AVMAPKI™ FAKZYNJA™ combination therapy (avutometinib capsules; defactinib tablets) data from the Phase 2 RAMP 201 clinical trial at the Society of Gynecologic Oncology (SGO) 2026 Annual Meeting on Women’s Cancers. Additional abstracts accepted for presentation will also be shared at the meeting being held on April 10-13, 2026, in San Juan, Puerto Rico.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) --

While investors chase the obvious opportunity in the emerging GLP-1, MASH Healthcare market, another potentially powerful theme is developing just beneath the surface.

As previously announced, JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) will host a conference call to review first-quarter 2026 financial results on Tuesday, April 14, 2026 at 8:30 a.m. (ET). The results are scheduled to be released at approximately 7:00 a.m. (ET). The live audio webcast and presentation slides will be available on www.jpmorganchase.com under Investor Relations, Events & Presentations.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PayPal Holdings, Inc. (“PayPal” or the “Company”) (NASDAQ: PYPL).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

VANCOUVER, British Columbia - March 17, 2026 - Robert Lawrence Vancouver has published a new restaurant review featuring Industry Apizza, a Vancouver pizza destination known for bringing New Haven-style apizza to the city. The latest review highlights the restaurant’s crisp, charred crust, balanced construction, and distinctive approach to pizza, placing it firmly in the conversation around the best pizza experiences in Vancouver.

Today, Fifth Third Bancorp announced the declaration of cash dividends on its common shares, Series H preferred shares, Series I preferred shares, Series J preferred shares, Series K preferred shares, Series M preferred shares, and Class B Series A preferred shares.

The U.S. blank apparel and textile manufacturing industry continues to expand as demand for customizable clothing, uniforms, and branded merchandise accelerates across corporate, promotional, and retail markets.

Antimony is rapidly emerging as one of the most strategically important critical minerals in the global resource race, particularly as defense technology, aerospace systems, and advanced electronics continue to expand. The metal is widely used to harden lead alloys in military ammunition, strengthen defense equipment, and produce flame-retardant materials used in aircraft wiring, armored vehicles, and protective gear. Antimony also plays an important role in semiconductors, infrared sensors, and specialized batteries used in drones, communications systems, and battlefield electronics .

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that preliminary results from an investigator-sponsored study evaluating botensilimab (BOT) in combination with balstilimab (BAL) in first-line microsatellite stable colorectal cancer (MSS CRC) will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 18–23 in San Diego, CA.

KASTAMONU, Türkiye - March 17, 2026 - Spontane Media Kastamonu, an independent digital media initiative founded by Turkish journalism student Berat Kaan Yılmaz, continues to expand its international media presence through global press distribution platforms while promoting local journalism and regional storytelling.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

Within the rarefied sphere of Fort Lauderdale architects, architecture becomes less about construction and more about authorship—an intellectual territory reserved for those who understand that space is a language through which power is quietly articulated. Studio KHORA operates precisely in this domain. Here, architecture is not decoration, but discourse: a system of signs, absences, and controlled tensions that allow each residence to emerge as a singular statement of identity. The house is no longer an object. It becomes a text—read, interpreted, and ultimately possessed.

Full Alliance Group (OTCQB: FAGI) continues executing its multi-vertical growth strategy as its subsidiary Aquaox Pure Solutions, LLC reports accelerating marketplace traction for JusSpray™, the company’s flagship hypochlorous acid (HOCl) skin defense spray.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced three of the Company’s internally-developed investigational oncology therapies will be presented across four poster sessions at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 taking place April 17-22 in San Diego, California. These next-generation candidates include: zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC) for small cell lung cancer (SCLC); ZL-6201, a leucine-rich repeat-containing protein 15 (LRRC15) ADC for the treatment of sarcoma and epithelial tumors with LRRC15 expressing cancer-associated fibroblasts (CAFs); and, ZL-1222, a PD-1 and interleukin-12 (IL-12) signaling attenuated mutein agonist immunocytokine for cancer immunotherapy.

SAN DIEGO and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that muzastotug will be highlighted in two poster presentations at this year’s AACR Meeting, taking place April 17-22 in San Diego, CA.

Synthekine Inc., an engineered cytokine therapeutics company, today announced that updated clinical and translational data from a Phase 1a/1b clinical trial of its α/β biased IL-2 partial agonist, STK-012, will be presented in an oral presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 taking place in San Diego, CA from April 17 - 22, 2026. In this now fully enrolled study, STK-012 is being evaluated in combination with standard-of-care pembrolizumab + chemotherapy in first-line nonsquamous (NSQ) non-small cell lung cancer (NSCLC) patients with features of immune resistance such as PD-L1 negative histology and STK11/KEAP1 mutations.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will present a poster on one of the three key mechanisms by which atebimetinib aims to improve overall survival: shrinking tumors durably. The poster will be presented at the American Association for Cancer Research (AACR) Annual Meeting taking place April 17-22, 2026 in San Diego, CA.

UK - Mar 17, 2026 - EarpieceOnline.co.uk has highlighted a growing need for discreet, high-quality communication tools across the retail, hospitality, and event sectors. With customer-facing teams requiring rapid communication that does not disrupt the customer experience, modern alternatives to traditional acoustic tubes, such as the Resowire earpiece, are increasingly becoming a frontline essential.

It is the quiet dread of every professional artist.You spend weeks on a commission. The brushwork is perfect. The client is thrilled. You ship the piece, confident that your work is done. But two months later, you get the email that makes your stomach drop. "The painting... it looks twisted."

UnitedHealth Group (NYSE: UNH) will release its first quarter 2026 financial results on Tuesday, April 21, 2026, before the market opens, and will host a teleconference at 8:00 a.m. ET with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through May 5, 2026, on the website.

ST. GALLEN, Switzerland, March 17, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced that Craig Felenstein, the Company’s Chief Financial Officer, will participate in the 38th Annual Roth Conference on Tuesday, March 24th, 2026. The fireside chat will take place at 1:30 pm eastern time. The webcast can be accessed at investors.sportradar.com.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ostin Technology Group Co., Ltd. (“Ostin” or the “Company”) (NASDAQ: OST).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

Texas King Haul LLC, a Houston-based dump truck and material delivery company, is expanding its services across the Greater Houston construction market with the goal of helping builders, contractors, developers, and property owners access reliable hauling and construction material solutions. The company aims to increase visibility for essential services such as dirt haul-off services, sand delivery, select fill delivery, and dump truck services in Houston.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced the completion of the acquisition of Bako Diagnostics, a premier pathology laboratory, and StrataDx, a premier dermatopathology laboratory, as previously announced on December 22, 2025.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced four presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlighting new data in molecular residual disease (MRD) testing and multi-cancer early detection (MCED). The meeting will take place from April 17–22, 2026, in San Diego, CA.

WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that a poster with preclinical data on the Company’s oral KAT6A selective degrader (PRT13722) has been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place from April 17-22.

Cambridge, MA - March 17, 2026 - Thrawn, a healthcare logistics startup, today announced the general availability of its managed physician scheduling service for residency and fellowship programs . The service uses a proprietary mathematical optimization engine to generate complete Block, Call, Clinic, and Attending schedules — eliminating the hundreds of hours chief residents and program directors currently spend building schedules manually in spreadsheets.

VANCOUVER, BC, March 17, 2026 – TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the “Company”) is providing this bi-weekly update on the status of the management cease trade order granted on March 3, 2026 (the “MCTO”), by its principal regulator, the British Columbia Securities Commission (the “BCSC”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). The Company announced on March 3, 2026 (the “Default Announcement”), that it was unable to file its audited annual financial statements for the year ended October 31, 2025, the related management’s discussion and analysis, and its Form 52-109FV1 CEO and CFO certifications of annual filings (collectively the “Annual Filings”). Under National Instrument 51-102 - Continuous Disclosure Obligations, the Annual Filings were required to be made not later than February 28, 2026.

Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, today announced the U.S. Department of Energy (DOE) has approved the Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy’s Groves Isotopes Test Reactor in Texas under the DOE’s Reactor Pilot Program (RPP).

Beazer Homes USA, Inc. (the “Company”) (NYSE: BZH) announced that it has entered into a third amendment to its existing senior unsecured revolving credit facility (“Credit Facility”) that increased the available aggregate commitment amount by $160 million to $525 million. The amendment also extends the maturity date of the Credit Facility from March 15, 2028 to March 13, 2030.

Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that it will present preclinical data on its FMC-242 program, as well as advances from its AI-powered Frontier™ Platform, at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22, 2026, in San Diego. FMC-242 is Frontier’s first-in-class allosteric breaker of the PI3Kα-RAS interaction that is in preclinical development for the treatment of solid tumors driven by RTK activation, RAS mutations and PI3Kα mutations, as both a single agent and in combination with other therapies including KRAS inhibitors.